Abstract
Hashimoto’s thyroiditis (HT) is a very common autoimmune disease of the thyroid. In addition to genetic background, several viruses, including herpesviruses, have been suggested to play a role as possible environmental triggers of disease, but conclusive data are still lacking. Previous results showed that HT patients have an increased cellular immune response directed against the HHV-6 U94 protein and increased NK activity directed against HHV-6 infected thyrocytes.
In this study, we characterized the antiviral antibody response and the NK cells activity and subtype in HHV-6 infected HT patients. The results showed that HT subjects have increased prevalence and titer of anti-U94 antibodies and a higher amount of CD3-CD56brightCD16−NK cell percentages compared to controls. Furthermore, the cell activation of CD3−CD56bright NK cells in HT patients significantly correlates with TPO and Tg Ab levels.
The results suggest that HHV-6 might contribute to HT development, increasing NK cell secretion of inflammatory cytokines that could sustain the persistence of an inflammatory status in HT patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alvarez-Lafuente R, Fernandez-Gutierrez B, de Miguel S, Jover JA, Rollin R, Loza E, Clemente D, Lamas JR (2005) Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 64(9):1357–1359. doi:64/9/1357 [pii]10.1136/ard.2004.033514
Alvarez-Lafuente R, Martinez A, Garcia-Montojo M, Mas A, De Las Heras V, Dominguez-Mozo MI, Maria Del Carmen C, Lopez-Cavanillas M, Bartolome M, Gomez de la Concha E, Urcelay E, Arroyo R (2010) MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur J Neurol 17(1):129–135. doi:ENE2758 [pii]10.1111/j.1468-1331.2009.02758.x
Bertelsen LBPC, Kofod-Olsen E, Oster B, Höllsberg P, Agger R, Hokland M (2010) Human herpesvirus 6B induces phenotypic maturation without IL-10 and IL-12p70 production in dendritic cells. Scand J Immunol 71(6):431–439
Boccara O, Lesage F, Regnault V, Lasne D, Dupic L, Bourdon-Lanoy E, Pannier S, Fraitag S, Audat F, Lecompte T, Hubert P, Bodemer C (2009) Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication. Br J Dermatol 161(1):181–183. doi:BJD9264 [pii]10.1111/j.1365-2133.2009.09264.x
Broccolo F, Drago F, Paolino S, Cassina G, Gatto F, Fusetti L, Matteoli B, Zaccaria E, Parodi A, Lusso P, Ceccherini-Nelli L, Malnati MS (2009) Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. J Clin Virol 46 (1):43–46. doi:S1386-6532(09)00191-7 [pii]10.1016/j.jcv.2009.05.010
Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D (2002) HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 67(4):528–533
Caruso A, Caselli E, Fiorentini S, Rotola A, Prandini A, Garrafa E, Saba E, Alessandri G, Cassai E, Di Luca D (2009) U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Proc Natl Acad Sci U S A 106(48):20446–20451. doi:0905535106 [pii]10.1073/pnas.0905535106
Caselli E, Di Luca D (2007) Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol 30(3):173–187
Caselli E, Boni M, Bracci A, Rotola A, Cermelli C, Castellazzi M, Di Luca D, Cassai E (2002) Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J Clin Microbiol 40(11):4131–4137
Caselli E, Bracci A, Galvan M, Boni M, Rotola A, Bergamini C, Cermelli C, Dal Monte P, Gompels UA, Cassai E, Di Luca D (2006) Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication. Virology 346(2):402–414
Caselli E, Zatelli MC, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, Degli Uberti EC, Di Luca D, Dolcetti R (2012a) Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s Thyroiditis. PLoS Pathog 8(10):e1002951. doi:10.1371/journal.ppat.1002951PPATHOGENS-D-12-01343 [pii]
Caselli E, Zatelli M, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, degli Uberti EC, Di Luca D, Dolcetti R (2012b) Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS Pathog 8:e1002951
Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M et al (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92(16):7440–7444
Cooper MAFT, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):633–640
Di Luca D, Dolcetti R, Mirandola P, De Re V, Secchiero P, Carbone A, Boiocchi M, Cassai E (1994) Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 170(1):211–215
Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS (1989) Viral genomes in lymphomas of patients with Sjogren’s syndrome. J Autoimmun 2(4):449–455
Gustafsson RK, Engdahl EE, Hammarfjord O, Adikari SB, Lourda M, Klingström J, Svensson M, Fogdell-Hahn A (2013) Human herpesvirus 6A partially suppresses functional properties of DC without viral replication. PLoS One 8(3):e58122
Hidaka YAN, Iwatani Y, Kaneda T, Nasu M, Mitsuda N, Tanizawa O, Miyai K (1992) Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 11:239
Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K (1991) Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72(Pt 6):1401–1408
Krueger GR, Sander C, Hoffmann A, Barth A, Koch B, Braun M (1991) Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. Vivo 5(3):217–225
Kubo T SK, Kobayashi D, Motegi A, Kobayashi O, Takeshita S, Nonoyama S (2006) A case of HHV-6 associated acute necrotizing encephalopathy with increase of CD56bright NKcells. Scand J Infect Dis 38(11–12):1122–1125
Kumagai TYT, Yoshida M, Okui T, Ihira M, Nagata N, Yano S, Shiraki K, Yamada M, Ichihara K, Asano Y (2006) Time course characteristics of human herpesvirus 6 specific cellular immune response and natural killer cell activity in patients with exanthema subitum. J Med Virol 78(6):792–799
Mikoś HMM, Obara-Moszyńska M, Niedziela M (2014) The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease(AITD). Endokrynol Pol 65(2):150–155
Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126(4):458–465. doi:IMM3027 [pii]10.1111/j.1365-2567.2008.03027.x
Potenza L, Luppi M, Barozzi P, Rossi G, Cocchi S, Codeluppi M, Pecorari M, Masetti M, Di Benedetto F, Gennari W, Portolani M, Gerunda GE, Lazzarotto T, Landini MP, Schulz TF, Torelli G, Guaraldi G (2008) HHV-6A in syncytial giant-cell hepatitis. N Engl J Med 359(6):593–602. doi:359/6/593 [pii]10.1056/NEJMoa074479
Ranger-Rogez S, Vidal E, Liozon F, Denis F (1994) Primary Sjogren’s syndrome and antibodies to human herpesvirus type 6. Clin Infect Dis 19(6):1159–1160
Rizzo RGV, Casetta I, Caselli E, De Gennaro R, Granieri E, Cassai E, Di Luca D, Rotola A (2012) Altered natural killer cells’ response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression. J Neuroimmunol 251:55–64
Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D (1998) U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A 95(23):13911–13916
Rotola A, Merlotti I, Caniatti L, Caselli E, Granieri E, Tola MR, Di Luca D, Cassai E (2004) Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler 10(4):348–354
Scotet E, Peyrat MA, Saulquin X, Retiere C, Couedel C, Davodeau F, Dulphy N, Toubert A, Bignon JD, Lim A, Vie H, Hallet MM, Liblau R, Weber M, Berthelot JM, Houssaint E, Bonneville M (1999) Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol 29(3):973–985
Storkus WJHD, Salter RD, Dawson JR, Cresswell P (1987) NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138(6):1657–1659
Thomas D, Liakos V, Michou V, Kapranos N, Kaltsas G, Tsilivakos V, Tsatsoulis A (2008) Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Diabetes 116(1):35–39
Vitale M, Della Chiesa M, Carlomagno S, Romagnani C, Thiel A, Moretta L, Moretta A (2004) The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34(6):1715–1722. doi:10.1002/eji.200425100
Wu ZSC, Reichel JJ, Just M, Mertens T (2015) Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses. J Virol 89(5):2906–2917
Acknowledgements
This work was supported by grants from University of Ferrara (FAR).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rizzo, R. et al. (2015). Increase in Peripheral CD3−CD56brightCD16− Natural Killer Cells in Hashimoto’s Thyroiditis Associated with HHV-6 Infection. In: Donelli, G. (eds) Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology(), vol 897. Springer, Cham. https://doi.org/10.1007/5584_2015_5010
Download citation
DOI: https://doi.org/10.1007/5584_2015_5010
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26319-9
Online ISBN: 978-3-319-26320-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)